The export restrictions has been lifted by the government on active pharmaceutical ingredients (API) and formulations of hydroxychloroquine (HCQ).
“Department of Pharmaceuticals has approved the lifting of ban on export of hydroxychloroquine APIs as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market. DGFT has been asked to issue formal notification in this regard.” Sadananda Gowda, Minister of Chemicals and Fertilisers told in a tweet.
As per the comments in her tweet, some appreciated the move while others expressed concerns over the increasing price of HCQ APIs and its impact on finished formulations
Sahil Munjal, Vice Chairman, Pharmexcil said, “We welcome the move, it is good news for hydroxychloroquine exporters and manufacturers. With this move, the industry also expects stability in the API prices of hydroxychloroquine.”